Special Issue "Adenoviruses: From Virus to Medicine"
A special issue of Biomedicines (ISSN 2227-9059).
Deadline for manuscript submissions: closed (30 November 2018)
Dr. Bernard Klonjkowski
Equipe « Vaccins et Vecteurs adénoviraux », Ecole Nationale Vétérinaire d’Alfort, 7 avenue du Général de Gaulle, 94700 Maisons-Alfort, France
Interests: non-human adenovirus; system vaccinology; innate immunity; antigen design; veterinary vaccine; foot-and-mouth disease; replicative vector; safety and toxicity of adenovirus administration
This Special Issue, "Adenoviruses: From Virus to Medicine", will focus on the various aspects of adenoviral biology, at the crossroads of knowledge between pathogens and gene delivery vectors.
Adenoviruses are associated with respiratory, enteric, and ocular diseases. More recently, adenovirus infections have become a major concern in recipients of organs/transplants. Furthermore, biotechnological platforms have been developed for several adenoviruses used in therapeutic and vaccine approaches.
This Special Issue will welcome original and innovative research, or review manuscripts, focusing on the biology of adenovirus infections and adenovirus-based vectors for gene therapy, oncotherapy, or vaccine purposes.
Dr. Bernard Klonjkowski
Dr. Mitesh J. Borad
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 550 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
innate and adaptive immunity
assessment of adeno-vector safety